Cargando…

Two percent lovastatin ointment as a pathogenesis-directed monotherapy for porokeratosis

Detalles Bibliográficos
Autores principales: Ugwu, Nelson, Choate, Keith A., Atzmony, Lihi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7519267/
https://www.ncbi.nlm.nih.gov/pubmed/33005717
http://dx.doi.org/10.1016/j.jdcr.2020.08.017
_version_ 1783587543995908096
author Ugwu, Nelson
Choate, Keith A.
Atzmony, Lihi
author_facet Ugwu, Nelson
Choate, Keith A.
Atzmony, Lihi
author_sort Ugwu, Nelson
collection PubMed
description
format Online
Article
Text
id pubmed-7519267
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-75192672020-09-30 Two percent lovastatin ointment as a pathogenesis-directed monotherapy for porokeratosis Ugwu, Nelson Choate, Keith A. Atzmony, Lihi JAAD Case Rep Case Report Elsevier 2020-08-22 /pmc/articles/PMC7519267/ /pubmed/33005717 http://dx.doi.org/10.1016/j.jdcr.2020.08.017 Text en © 2020 by the American Academy of Dermatology, Inc. Published by Elsevier, Inc. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Case Report
Ugwu, Nelson
Choate, Keith A.
Atzmony, Lihi
Two percent lovastatin ointment as a pathogenesis-directed monotherapy for porokeratosis
title Two percent lovastatin ointment as a pathogenesis-directed monotherapy for porokeratosis
title_full Two percent lovastatin ointment as a pathogenesis-directed monotherapy for porokeratosis
title_fullStr Two percent lovastatin ointment as a pathogenesis-directed monotherapy for porokeratosis
title_full_unstemmed Two percent lovastatin ointment as a pathogenesis-directed monotherapy for porokeratosis
title_short Two percent lovastatin ointment as a pathogenesis-directed monotherapy for porokeratosis
title_sort two percent lovastatin ointment as a pathogenesis-directed monotherapy for porokeratosis
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7519267/
https://www.ncbi.nlm.nih.gov/pubmed/33005717
http://dx.doi.org/10.1016/j.jdcr.2020.08.017
work_keys_str_mv AT ugwunelson twopercentlovastatinointmentasapathogenesisdirectedmonotherapyforporokeratosis
AT choatekeitha twopercentlovastatinointmentasapathogenesisdirectedmonotherapyforporokeratosis
AT atzmonylihi twopercentlovastatinointmentasapathogenesisdirectedmonotherapyforporokeratosis